TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32803888

Group type: EXPERIMENTAL
Intervention: Lindera strychnifolia root extract (LsR) treatment for 83 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (AGA subjects without treatment)
Number of subjects: 24
Study: 35981315

Group type: EXPERIMENTAL
Intervention: Narrative intervention group (reading two tailored narrative messages about HPV/HPV vaccination)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (reading standard Center for Disease Control information)
Number of subjects: 101
Study: 33947293

Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Allied staff
Number of subjects: 684

Group type: COMPARATOR
Intervention: Care assistants
Number of subjects: 684
Study: 32384095

Group type: EXPERIMENTAL
Intervention: Handwashing with soap at critical times (doers)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-doers (those who do not wash their hands with soap at critical times)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-doers in the second camp
Number of subjects: 90
Study: 36081953

Group type: EXPERIMENTAL
Intervention: QL1209 420 mg intravenously
Number of subjects: 137

Group type: COMPARATOR
Intervention: Perjeta® 420 mg intravenously
Number of subjects: 137
Study: 33461151

Group type: EXPERIMENTAL
Intervention: 12-minute sub-maximal fitness test on a cycle ergometer
Number of subjects: 140
Study: 34169539

Group type: EXPERIMENTAL
Intervention: LHA intervention (n=23) - four-chapter one-on-one lesson plan over 4 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (n=28) - received only a health brochure
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: LHA intervention (n=23)
Number of subjects: 51
Study: 34086616

Group type: EXPERIMENTAL
Intervention: Third-party health websites
Number of subjects: 0

Group type: COMPARATOR
Intervention: Academic and nonacademic orthopaedic surgeons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Male and female providers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgeons from different graduation years
Number of subjects: 0
Study: 36163060

Group type: EXPERIMENTAL
Intervention: New incision made regardless of the previous scar location (intervention group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: New incision made at least 8 cm distant from the old incision (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Knee Society Score (KSS) at 6 months (intervention group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Knee Society Score (KSS) at 6 months (control group)
Number of subjects: 50
Study: 34228875

Group type: EXPERIMENTAL
Intervention: 10-mg oral solution oxycodone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20-mg controlled-release (water-swellable or lipid-based) oxycodone
Number of subjects: 20
Study: 32092187

Group type: EXPERIMENTAL
Intervention: LCP‐tac and everolimus once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: LCP‐tac and mycophenolate BID (control arm)
Number of subjects: 40
Study: 35835346

Group type: EXPERIMENTAL
Intervention: Ward-based goal-directed fluid therapy (GDFT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 50
Study: 34520293

Group type: EXPERIMENTAL
Intervention: CauchyCP test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing treatment comparison tests under non-proportional hazards
Number of subjects: 0
Study: 35638455

Group type: EXPERIMENTAL
Intervention: 3% NaCl solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: 30% NaCl solution
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Parental satisfaction
Number of subjects: 100
Study: 34218702

Group type: EXPERIMENTAL
Intervention: 4-channel NMES
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 52
Study: 32521556

Group type: EXPERIMENTAL
Intervention: Voice-Generated Enhanced Electronic Note System (VGEENS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Keyboard with template (control)
Number of subjects: 31
Study: 36088270

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen (10mg/kg/6h)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intravenous ketorolac (0.5mg/kg/6h)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Number of subjects: 66
Study: 32147962

Group type: EXPERIMENTAL
Intervention: Cash transfers and monthly group nutrition education sessions led by community health volunteers
Number of subjects: 1945
Study: 34732201

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 344
Study: 33836388

Group type: EXPERIMENTAL
Intervention: Topical ketamine cream 10%
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 5% EMLA cream
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (2 g of cold cream)
Number of subjects: 300
Study: 32143653

Group type: COMPARATOR
Intervention: Baseline altitude
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High altitude (3454 m above sea level)
Number of subjects: 20
Study: 36469647

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 80
Study: 33508845

Group type: EXPERIMENTAL
Intervention: Predialytic oral nutritional supplements (ONS) (450 kcal energy, 20 g protein) administered 1 hour prior to dialysis
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intradialytic oral nutritional supplements (ONS) (450 kcal energy, 20 g protein) administered after 2 hours of dialysis
Number of subjects: 72
Study: 32604256

Group type: EXPERIMENTAL
Intervention: Active in-home portable air cleaners (PACs) with HEPA filter
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham in-home portable air cleaners (PACs)
Number of subjects: 20
Study: 33768702

Group type: EXPERIMENTAL
Intervention: Olanzapine and chlorpromazine as add-on to lithium
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study: 32059039

Group type: EXPERIMENTAL
Intervention: Stroke identification algorithm using claims data
Number of subjects: 40443
Study: 33565209

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP-1 RA
Number of subjects: 0
Study: 32003257

Group type: EXPERIMENTAL
Intervention: Continuous Number Identification Test (CNIT)
Number of subjects: 10
Study: 35172685

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin plus chemotherapy (A + CHP)
Number of subjects: 0
Study: 33602431

Group type: EXPERIMENTAL
Intervention: Radial access crossover
Number of subjects: 8404

Group type: COMPARATOR
Intervention: Successful radial access
Number of subjects: 8404

Group type: COMPARATOR
Intervention: Successful femoral access
Number of subjects: 8404

Group type: EXPERIMENTAL
Intervention: Femoral access crossover
Number of subjects: 8404
Study: 35661358

Group type: EXPERIMENTAL
Intervention: 90% bovine‐derived xenograft granules in a 10% porcine collagen matrix (Group A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 80% microparticulate hydroxyapatite alloplast graft with 20% sugar cross‐linked porcine type 1 collagen (Group B)
Number of subjects: 54
Study: 35751090

Group type: EXPERIMENTAL
Intervention: Titanium (group TI; N=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PEEK (group PE; N=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PEKK (group PK; N=20)
Number of subjects: 60
Study: 33882949

Group type: EXPERIMENTAL
Intervention: Telerobotic assistance during locomotion
Number of subjects: 6
Study: 32755889

Group type: EXPERIMENTAL
Intervention: TRavelVU Plus app
Number of subjects: 17
Study: 34514706

Group type: EXPERIMENTAL
Intervention: Solution-Focused Support Program (SFSP), 4 sessions of online support, 1 session per week
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study: 32169003

Group type: EXPERIMENTAL
Intervention: Support group for typically developing siblings; details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Similar group without a focus on the sibling with autism spectrum disorder; details on dosage and duration not available.
Number of subjects: 0
Study: 32116139

Group type: EXPERIMENTAL
Intervention: Artificial food coloring (AFC) 225 mg in chocolate cookies for 3 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo chocolate cookies for 3 days
Number of subjects: 29
Study: 33964196

Group type: EXPERIMENTAL
Intervention: Epidural solution of bupivacaine 1 mg mL-1, fentanyl 2 μg mL-1 with adrenaline 2 μg mL-1
Number of subjects: 36

Group type: COMPARATOR
Intervention: Epidural solution of bupivacaine 1 mg mL-1, fentanyl 2 μg mL-1 without adrenaline
Number of subjects: 36
Study: 34855208

Group type: EXPERIMENTAL
Intervention: Interpersonal care (INT)
Number of subjects: 943

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 943

Group type: COMPARATOR
Intervention: Enhanced care (ENH)
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: All groups (UC, ENH, INT)
Number of subjects: 943
Study: 34292210

Group type: EXPERIMENTAL
Intervention: Laparoscopic liver surgery (LLS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Open liver surgery (OLS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both LLS and OLS
Number of subjects: 36
Study: 32371558

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 0
Study: 35225089

Group type: EXPERIMENTAL
Intervention: Positive episodic future thinking
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Neutral episodic future thinking
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Negative episodic future thinking
Number of subjects: 572
Study: 32559809

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy (PM) for head and neck cancer (HNC)
Number of subjects: 44
Study: 33508334

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Seated rest condition
Number of subjects: 20
Study: 33091360

Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCBs)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Drug-eluting stents (DESs)
Number of subjects: 758
Study: 35674835

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Clopidogrel (600-mg loading dose)
Number of subjects: 49
Study: 34132753

Group type: EXPERIMENTAL
Intervention: Skeletonized internal mammary artery harvesting
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Pedicled internal mammary artery harvesting
Number of subjects: 1002
Study: 32002547

Group type: EXPERIMENTAL
Intervention: 5-fraction stereotactic radiosurgery (SRS) with 5-mm margins at 40 Gy
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5-fraction stereotactic radiosurgery (SRS) with 5-mm margins at 25, 30, 35 Gy
Number of subjects: 30
Study: 35148516

Group type: EXPERIMENTAL
Intervention: 0.4 mg oral tamsulosin for 5 days preoperatively and 2 days postoperatively
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo for 5 days preoperatively and 2 days postoperatively
Number of subjects: 610
Study: 33573896

Group type: EXPERIMENTAL
Intervention: Group A: Periodontal scaling once a month
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B: Periodontal scaling once every 3 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group C: Periodontal scaling once every 6 months
Number of subjects: 48
Study: 32955832

Group type: EXPERIMENTAL
Intervention: HIIT-A
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HIIT-AR
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 35014965

Group type: EXPERIMENTAL
Intervention: Test group (n=191)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Validation group (n=191)
Number of subjects: 382
Study: 32959584

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST 36) in group A
Number of subjects: 63

Group type: COMPARATOR
Intervention: Electroacupuncture at Zusanli (ST 36) and Zhongwan (CV 12) in group B
Number of subjects: 63
Study: 36322937

Group type: EXPERIMENTAL
Intervention: Moderate-dose hydroxyurea (20 mg/kg per day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Low-dose hydroxyurea (10 mg/kg per day)
Number of subjects: 101
Study: 35724939

Group type: EXPERIMENTAL
Intervention: Flowable resin composite (Tetric Evo Flow)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sealant material (Helioseal F)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both materials (Tetric Evo Flow and Helioseal F)
Number of subjects: 34
Study: 32041658

Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide 4-6 µg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glycopyrronium bromide 4 µg/kg (active placebo)
Number of subjects: 40
Study: 35033468

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 6932

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 6932
Study: 33030992

Group type: EXPERIMENTAL
Intervention: Unemployed mothers
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Medicaid eligible mothers
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Less educated mothers
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Smoking mothers
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Mothers providing less skin-to-skin care
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Mothers delaying the decision to provide milk
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Minutes of skin-to-skin care
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Insufficient maternal milk production
Number of subjects: 142
Study: 33787833

Group type: EXPERIMENTAL
Intervention: Music system intervention used during nursing activities
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no music system intervention)
Number of subjects: 18
Study: 32076866

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 5% CHX
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10% essential oils (EO)
Number of subjects: 80

Group type: COMPARATOR
Intervention: water
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: essential oils (EO)
Number of subjects: 80
Study: 35971150

Group type: EXPERIMENTAL
Intervention: e‐cigarettes with 18 mg/ml nicotine
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: e‐cigarettes without nicotine
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: NRT
Number of subjects: 248
Study: 33975901

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver followed by 5 cm H2O of PEEP (RM5 group)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver followed by 10 cm H2O of PEEP (RM10 group)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Volume control ventilation with 5 cm H2O of PEEP (control group)
Number of subjects: 192
Study: 32780736

Group type: EXPERIMENTAL
Intervention: Proposed approach for identifying machine-interpretable topics using Linked Open Data (LOD).
Number of subjects: 1000000

Group type: COMPARATOR
Intervention: Traditional words-list-based representations for topic identification.
Number of subjects: 1000000
Study: 35182043

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 12 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 36 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33118927

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi), n = 72
Number of subjects: 145

Group type: COMPARATOR
Intervention: No-treatment control, n = 73
Number of subjects: 145
Study: 35351238

Group type: EXPERIMENTAL
Intervention: Short regimen (including moxifloxacin and clofazimine)
Number of subjects: 282
Study: 35671086

Group type: EXPERIMENTAL
Intervention: NRD.E1 at 40 mg/day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: NRD.E1 at 150 mg/day
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: NRD.E1
Number of subjects: 88
Study: 33965188

Group type: EXPERIMENTAL
Intervention: Leucovorin (LCV) following MTX
Number of subjects: 46

Group type: COMPARATOR
Intervention: Historical controls (no LCV)
Number of subjects: 46
Study: 32528172

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Older children (boys and girls)
Number of subjects: 1284
Study: 34996593

Group type: EXPERIMENTAL
Intervention: Intermittent prophylactic face-mask noninvasive ventilation (NIV) for 6-8 hours per day
Number of subjects: 266

Group type: COMPARATOR
Intervention: Usual postoperative care
Number of subjects: 266
Study: 33548056

Group type: EXPERIMENTAL
Intervention: Social support pre-treatment
Number of subjects: 2858

Group type: EXPERIMENTAL
Intervention: Severe lack of social support
Number of subjects: 2858
Study: 36309984

Group type: EXPERIMENTAL
Intervention: Combination therapy with Simvastatin and Ezetimibe
Number of subjects: 2029

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2029
Study: 33649098

Group type: EXPERIMENTAL
Intervention: Rituximab (1 g) on days 1 and 15
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cyclic regimen with corticosteroids and cyclophosphamide
Number of subjects: 74
Study: 36017205

Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WBE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Land-based exercise (LBE)
Number of subjects: 60
Study: 33389614

Group type: EXPERIMENTAL
Intervention: Combined mammography and adjunctive ultrasound
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mammography alone
Number of subjects: 0
Study: 32558226

Group type: EXPERIMENTAL
Intervention: Remote patient monitoring
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 56
Study: 35517806

Group type: EXPERIMENTAL
Intervention: Crocin supplementation (30 mg/day for 12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33589246

Group type: EXPERIMENTAL
Intervention: OCHRA feedback
Number of subjects: 50

Group type: COMPARATOR
Intervention: OSATS feedback
Number of subjects: 50
Study: 34991056

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) at 10-30 mg/kg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (previous treatment)
Number of subjects: 42
Study: 34055121

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 76

Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 76
Study: 36106611

Group type: EXPERIMENTAL
Intervention: Proteus Discover (PD) with TDF/FTC
Number of subjects: 100

Group type: COMPARATOR
Intervention: TDF/FTC standard-of-care
Number of subjects: 100
Study: 33512065

Group type: COMPARATOR
Intervention: KHK4083 (10 mg/kg, single intravenous dose)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: KHK4083 (multiple intravenous doses)
Number of subjects: 36
Study: 36346336

Group type: EXPERIMENTAL
Intervention: Oral health promotion management
Number of subjects: 0
Study: 36398451

Group type: EXPERIMENTAL
Intervention: BMI reporting intervention
Number of subjects: 9665

Group type: EXPERIMENTAL
Intervention: 1 round of BMI reporting
Number of subjects: 9665

Group type: EXPERIMENTAL
Intervention: 2 rounds of BMI reporting
Number of subjects: 9665
Study: 33668058

Group type: EXPERIMENTAL
Intervention: Protein-rich (PROT) diet
Number of subjects: 163

Group type: COMPARATOR
Intervention: Carbohydrate-rich (CARB) diet
Number of subjects: 163

Group type: COMPARATOR
Intervention: Unsaturated fat-rich (UNSAT) diet
Number of subjects: 163
Study: 35627807

Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (non-animal-related recreational activities)
Number of subjects: 40
Study: 32912828

Group type: EXPERIMENTAL
Intervention: School-based randomized intervention trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incentives for participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Final survey participation
Number of subjects: 0
Study: 34031888

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34472756

Group type: EXPERIMENTAL
Intervention: Acupuncture at 'ghost points' combined with acupoints selected by syndrome differentiation
Number of subjects: 124

Group type: COMPARATOR
Intervention: Routine rehabilitation treatment
Number of subjects: 124
Study: 33767376

Group type: EXPERIMENTAL
Intervention: High protein regimen (18% energy intake as amino acids, targeting 4 g/kg/day)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional regimen (12.5% energy intake as amino acids, targeting 3 g/kg/day)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High protein regimen
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional regimen
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study: 34461161

Group type: EXPERIMENTAL
Intervention: High dose oral thiamine (one gram twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 34729774

Group type: EXPERIMENTAL
Intervention: Standard care plus the interprofessional student-run medication review program (ISP)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 216
Study: 36356395

Group type: EXPERIMENTAL
Intervention: Combined cognitive-behavioral intervention
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Cognitive-only expectancy challenge
Number of subjects: 159

Group type: COMPARATOR
Intervention: Neutral reading (control) task
Number of subjects: 159
Study: 34488269

Group type: EXPERIMENTAL
Intervention: Narrative therapy (once a week for 30 min over 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine clinical treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Narrative therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60